Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke

Thrombosis Research

Volumn 127, Issue 1, 2011, Pages 51-56

  Rooth, E ^a   Wallen, N H ^a   Blomback M ^b   He, S ^a,b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrin network permeability; Fibrinogen; Fibrinolysis profile; Ischemic stroke; PAI 1

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FIBRIN; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN;

ACUTE DISEASE; AGED; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FIBRIN FORMATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HUMAN CELL; MALE; PERMEABILITY; PRIORITY JOURNAL; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROKE; SWEDEN; THROMBOPLASTIN; TIME FACTORS;

EID: 78650450066     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.09.011     Document Type: Article

References (35)

1. C. Warlow, M. Dennis, J. van Gijn, G. Hankey, P. Sandercock, and J. Bamford A practical guide to management Stroke 1996 Oxford: Blackwell
2. W. Wysokinski, W. Owen, D. Fass, D. Patrzalek, L. Murphy, and R. McBane Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi J Thromb Haemost 2 9 2004 1637 1644
3. B. Blombäck, K. Carlsson, B. Hessel, A. Liljeborg, R. Procyk, and N. Aslund Native fibrin gel networks observed by 3D microscopy, permeation and turbidity Biochim Biophys Acta 997 1-2 1989 96 110
4. B. Blombäck, K. Carlsson, K. Fatah, B. Hessel, and R. Procyk Fibrin in human plasma gel architectures governed by rate and nature of fibrinogen activation Thromb Res 75 5 1994 521 538
5. J. Collet, Z. Mishal, C. Lesty, M. Mirshahi, J. Peyne, and A. Baumelou Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 82 5 1999 1482 1489
6. A. Silveira, and A. Hamsten Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease Arterioscler Thromb Vasc Biol 26 11 2006 2419 2420
7. S. He, G. Jacobsson-Ekman, and U. Hedner The role of recombinant activated Factor VII (rVIIa) in the fibrin structure in the absence of FVIII/FVIX J Thromb Haemost 1 6 2003 1215 1219
8. S. He, N. Bark, H. Wang, J. Svensson, and M. Blombäck Effects of Acetylsalicylic Acid on Increase of Fibrin Network Porosity and the Consequent Upregulation of Fibrinolysis J Cardiovasc Pharmacol 53 1 2009 24 29
9. G. Jörneskog, N. Egberg, B. Fagrell, K. Fatah, B. Hessel, and H. Johnsson Altered properties of the fibrin gel structure in patients with IDDM Diabetologia 39 12 1996 1519 1523
10. K. Fatah, A. Hamsten, B. Blombäck, and M. Blombäck Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentrations, acute phase protein, serum lipoproteins and coronary atherosclerosis Thromb Haemost 68 2 1992 130 135
11. K. Fatah, A. Silveira, P. Tornvall, F. Karpe, M. Blombäck, and A. Hamsten Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at young age Thromb Haemost 76 4 1996 535 540
12. W. Hacke, G. Donnan, C. Fieschi, M. Kaste, R. von Kummer, and J. Broderick Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 9411 2004 768 774
13. M. Ribo, J. Montaner, C. Molina, J. Arenillas, E. Santamarina, and J. Alvarez-Sabín Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator Thromb Haemost 91 6 2004 1146 1151 (Pubitemid 38821271)
14. Undas A., Slowik A., Wolkow P., Szczudlik A., Tracz W. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit. Thromb Res 2010;125(4):357-61.
15. T. Brott, H. Adams Jr, C. Olinger, J. Marler, W. Barsan, and J. Biller Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 7 1989 864 870 (Pubitemid 19188240)
16. H. Adams Jr, B. Bendixen, L. Kapelle, J. Biller, B. Love, and D. Gordon Classification of subtype of acute ischemic stroke-definitions for use in a multicenter clinical trial. TOAST. Trial of Org10172 in Acute Stroke Treatment Stroke 24 1 1993 35 41
17. J. van Swieten, P. Koudstaal, M. Visser, H. Schouten, and J. van Gijn Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 5 1988 604 607
18. S. He, K. Zhu, M. Skeppholm, J. Vedin, J. Svensson, and N. Egberg A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma Thromb Haemost 98 4 2007 871 882
19. S. He, H. Cao, A. Antovic, and M. Blombäck Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials Blood Coag Fibrinolysis 16 1 2005 61 67
20. M. Carr, L. Shen, and J. Hermans Mass-length ratio of fibrin fibers from gel permeation and light scattering Biopolymers 16 1 1977 1 15
21. C. Faber, J. Lodder, F. Kessels, and J. Troost Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients Patophysiol Haemost Thromb 33 1 2003 52 58
22. S. He, G. Ekman, and U. Hedner The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombastenia J Thromb Haemost 3 2 2005 272 279
23. E. Bevers, P. Comfurius, and R. Zwaal Platelet procoagulant activity: physiological significance and mechanisms of exposure Blood Rev 5 3 1991 146 154
24. B. Blombäck, and M. Okada Fibrin gel structure and clotting time Thromb Res 25 1-2 1982 51 70
25. A. Antovic, C. Perneby, G. Ekman, H. Wallén, P. Hjemdahl, and M. Blombäck Marked increase of fibrin gel permeability with very low dose ASA treatment Thromb Res 116 6 2005 509 517
26. R. Kumar, S. Béguin, and H. Hemker The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity Thromb Haemost 74 3 1995 962 968
27. S. Béguin, R. Kumar, I. Keularts, U. Seligsohn, B. Coller, and H. Hemker Fibrin-dependent platelet procoagulant activity requires GP1b receptors and von Willebrand factor Blood 93 2 1999 564 570
28. H. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. De Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophys Haemost Thromb 33 1 2003 4 15
29. E. Dunn, R. Ariëns, and P. Grant The influence of type 2 diabetes on fibrin structure and function Diabetologia 48 6 2005 1198 1206
30. P. Zunker, A. Schick, T. Padró, J. Kienast, A. Phillips, and E.B. Ringelstein Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology Neurol Res 21 8 1999 727 732
31. Z.B. Jovanović, M. Ilić, J. Zidverc-Trajković, A.M. Pavlović, M. Mijajlović, and N. Sterić Plasminogen activator inhibitor-1 in the evolution of stroke Srp Arh Celok Lek 132 5-6 2004 143 147
32. E. Rooth, H. Wallén, A. Antovic, M. von Arbin, G. Kaponides, and N. Wahlgren Thrombin activatable fibrinolysis inhibitor and its relations to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke Blood Coag Fibrinolysis 18 4 2007 365 370
33. J. Wiesel Structure of fibrin: impact on clot stability J Thromb Haemost 5 Suppl 1 2007 116 124
34. M. Soncini, P. Gasparini, M. Lorena, A. Motta, and C. Cimminiello Prognostic significance of markers of thrombin generation in the acute and cronic phases of non cardioembolic ischemic stroke Minerva Cardioangiol 48 11 2000 349 356
35. A. Undas, M. Celinska-Löwenhoff, T. Löwenhoff, and A. Szczeklik Statins, fenofibrate and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease J Thromb Haemost 4 5 2006 1029 1036